Goodlad R A, Ghatei M A, Bloom S R, Wright N A
Imperial Cancer Research Fund, Histopathology Unit, London.
Exp Physiol. 1991 Nov;76(6):943-9. doi: 10.1113/expphysiol.1991.sp003556.
The hypothesis that glucagon 1-21 (G1-21) is trophic to the gastrointestinal tract was investigated in the hypoplastic intestine of intravenously maintained rats. Three groups of eight rats were fed parenterally for three days and then were infused with either 0, 20 or 80 micrograms rat-1 day-1 of G1-21 for 3 days. No significant effect on the weight of the stomach, caecum or colon was observed, but both the weight and crypt cell production rate of the small intestine were significantly decreased by G1-21. Plasma enteroglucagon was also decreased by G1-21 treatment. It is concluded that G1-21 does not have a trophic effect on the gastrointestinal tract, and, in fact, has an antiproliferative effect on the small intestine, which could in turn be modulated by decreased levels of endogenous enteroglucagon.
在静脉维持营养的大鼠发育不全的肠道中,研究了胰高血糖素1 - 21(G1 - 21)对胃肠道具有营养作用这一假说。将三组每组八只大鼠进行三天的肠外营养喂养,然后分别以每天每只大鼠0、20或80微克的剂量注入G1 - 21,持续3天。未观察到对胃、盲肠或结肠重量有显著影响,但G1 - 21使小肠重量和隐窝细胞产生率均显著降低。G1 - 21治疗还使血浆肠高血糖素降低。得出的结论是,G1 - 21对胃肠道没有营养作用,实际上对小肠具有抗增殖作用,而这反过来可能受到内源性肠高血糖素水平降低的调节。